🇺🇸 Fosfomycin Trometamol Salt in United States

4 US adverse-event reports

Marketing authorisation

FDA

Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Window: 20 April 2025 – 20 April 2026
Total reports: 4

Most-reported reactions

Agitation — 1 report (25%)
Insomnia — 1 report (25%)
Mood Altered — 1 report (25%)
Quality Of Life Decreased — 1 report (25%)

Source database →

Fosfomycin Trometamol Salt in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

🇨🇦 Canada

Frequently asked questions

Is Fosfomycin Trometamol Salt approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Fosfomycin Trometamol Salt in United States?

Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina is the originator. The local marketing authorisation holder may differ — check the official source linked above.